These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 35627253)

  • 1. A New Zebrafish Model to Measure Neuronal α-Synuclein Clearance In Vivo.
    Lopez A; Gorb A; Palha N; Fleming A; Rubinsztein DC
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GV-971 attenuates α-Synuclein aggregation and related pathology.
    Yu Z; Yang Y; Chan RB; Shi M; Stewart T; Huang Y; Liu Z; Lan G; Sheng L; Tian C; Yang D; Zhang J
    CNS Neurosci Ther; 2024 Feb; 30(2):e14393. PubMed ID: 37563872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies?
    Fujita M; Sekigawa A; Sekiyama K; Sugama S; Hashimoto M
    J Neurol; 2009 Aug; 256 Suppl 3():286-92. PubMed ID: 19711118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Update on the Critical Role of α-Synuclein in Parkinson's Disease and Other Synucleinopathies: from Tissue to Cellular and Molecular Levels.
    Serratos IN; Hernández-Pérez E; Campos C; Aschner M; Santamaría A
    Mol Neurobiol; 2022 Jan; 59(1):620-642. PubMed ID: 34750787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
    Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FKBP12-immunopositive inclusions in patients with α-synucleinopathies.
    Honjo Y; Ayaki T; Horibe T; Ito H; Takahashi R; Kawakami K
    Brain Res; 2018 Feb; 1680():39-45. PubMed ID: 29246765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human amyloid beta and α-synuclein co-expression in neurons impair behavior and recapitulate features for Lewy body dementia in Caenorhabditis elegans.
    Huang X; Wang C; Chen L; Zhang T; Leung KL; Wong G
    Biochim Biophys Acta Mol Basis Dis; 2021 Oct; 1867(10):166203. PubMed ID: 34146705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy.
    Nimmo JT; Verma A; Dodart JC; Wang CY; Savistchenko J; Melki R; Carare RO; Nicoll JAR
    Alzheimers Res Ther; 2020 Nov; 12(1):159. PubMed ID: 33256825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models.
    Zhu Q; Zhuang XX; Chen JY; Yuan NN; Chen Y; Cai CZ; Tan JQ; Su HX; Lu JH
    Phytomedicine; 2021 Jul; 87():153578. PubMed ID: 34038839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher levels of myelin phospholipids in brains of neuronal α-Synuclein transgenic mice precede myelin loss.
    Grigoletto J; Pukaß K; Gamliel A; Davidi D; Katz-Brull R; Richter-Landsberg C; Sharon R
    Acta Neuropathol Commun; 2017 May; 5(1):37. PubMed ID: 28482862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells.
    Kim C; Kwon S; Iba M; Spencer B; Rockenstein E; Mante M; Adame A; Shin SJ; Fields JA; Rissman RA; Lee SJ; Masliah E
    Exp Mol Med; 2021 Feb; 53(2):281-290. PubMed ID: 33594256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease.
    Kasen A; Houck C; Burmeister AR; Sha Q; Brundin L; Brundin P
    Neurobiol Dis; 2022 May; 166():105654. PubMed ID: 35143968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.
    Poehler AM; Xiang W; Spitzer P; May VE; Meixner H; Rockenstein E; Chutna O; Outeiro TF; Winkler J; Masliah E; Klucken J
    Autophagy; 2014; 10(12):2171-92. PubMed ID: 25484190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of Lewy Body Pathology by Oral Cinnamon.
    Raha S; Dutta D; Roy A; Pahan K
    J Neuroimmune Pharmacol; 2021 Sep; 16(3):592-608. PubMed ID: 32889602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting Alpha Synuclein Seeding Activity in Formaldehyde-Fixed MSA Patient Tissue by PMCA.
    Becker K; Wang X; Vander Stel K; Chu Y; Kordower J; Ma J
    Mol Neurobiol; 2018 Nov; 55(11):8728-8737. PubMed ID: 29589283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential.
    Ferreira N; Gram H; Sorrentino ZA; Gregersen E; Schmidt SI; Reimer L; Betzer C; Perez-Gozalbo C; Beltoja M; Nagaraj M; Wang J; Nowak JS; Dong M; Willén K; Cholak E; Bjerregaard-Andersen K; Mendez N; Rabadia P; Shahnawaz M; Soto C; Otzen DE; Akbey Ü; Meyer M; Giasson BI; Romero-Ramos M; Jensen PH
    Acta Neuropathol; 2021 Jul; 142(1):87-115. PubMed ID: 33978813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.
    Vaikath NN; Majbour NK; Paleologou KE; Ardah MT; van Dam E; van de Berg WD; Forrest SL; Parkkinen L; Gai WP; Hattori N; Takanashi M; Lee SJ; Mann DM; Imai Y; Halliday GM; Li JY; El-Agnaf OM
    Neurobiol Dis; 2015 Jul; 79():81-99. PubMed ID: 25937088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies.
    Kawahata I; Finkelstein DI; Fukunaga K
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep-controlling neurons are sensitive and vulnerable to multiple forms of α-synuclein: implications for the early appearance of sleeping disorders in α-synucleinopathies.
    Dos Santos AB; Skaanning LK; Thaneshwaran S; Mikkelsen E; Romero-Leguizamón CR; Skamris T; Kristensen MP; Langkilde AE; Kohlmeier KA
    Cell Mol Life Sci; 2022 Jul; 79(8):450. PubMed ID: 35882665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.
    Castro-Sánchez S; García-Yagüe ÁJ; López-Royo T; Casarejos M; Lanciego JL; Lastres-Becker I
    Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.